177 related articles for article (PubMed ID: 28576663)
21. Effect of ranolazine on symptom and quality of life in patients with angina in the absence of obstructive coronary artery disease: A case control study.
Pargaonkar VS; Tremmel JA; Schnittger I; Khandelwal A
Int J Cardiol; 2020 Jun; 309():8-13. PubMed ID: 32220488
[TBL] [Abstract][Full Text] [Related]
22. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
[TBL] [Abstract][Full Text] [Related]
23. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
[TBL] [Abstract][Full Text] [Related]
24. Correlation between coronary microvascular function and angina status in patients with stable microvascular angina.
Di Franco A; Villano A; Di Monaco A; Lamendola P; Russo G; Stazi A; Scavone G; Nerla R; Sestito A; Lanza GA; Crea F
Eur Rev Med Pharmacol Sci; 2014; 18(3):374-9. PubMed ID: 24563437
[TBL] [Abstract][Full Text] [Related]
25. ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.
Sinha A; Rahman H; Douiri A; Demir OM; De Silva K; Clapp B; Webb I; Gulati A; Pinho P; Dutta U; Ellis H; Shah AM; Chiribiri A; Marber M; Webb AJ; Perera D
Circulation; 2024 Jan; 149(1):36-47. PubMed ID: 37905403
[TBL] [Abstract][Full Text] [Related]
26. Ranolazine for Symptomatic Management of Microvascular Angina.
Rayner-Hartley E; Parvand M; Humphries KH; Starovoytov A; Park JE; Sedlak T
Am J Ther; 2020; 27(2):e151-e158. PubMed ID: 29746286
[TBL] [Abstract][Full Text] [Related]
27. Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
Murai T; Kanaji Y; Yonetsu T; Lee T; Matsuda J; Usui E; Araki M; Niida T; Isobe M; Kakuta T
Catheter Cardiovasc Interv; 2017 Feb; 89(2):233-242. PubMed ID: 27219714
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.
Arnold SV; McGuire DK; Spertus JA; Li Y; Yue P; Ben-Yehuda O; Belardinelli L; Jones PG; Olmsted A; Chaitman BR; Kosiborod M
Am Heart J; 2014 Oct; 168(4):457-465.e2. PubMed ID: 25262254
[TBL] [Abstract][Full Text] [Related]
29. Ranolazine and Microvascular Angina by PET in the Emergency Department: Results From a Pilot Randomized Controlled Trial.
Safdar B; D'Onofrio G; Dziura J; Russell RR; Johnson C; Sinusas AJ
Clin Ther; 2017 Jan; 39(1):55-63. PubMed ID: 28081848
[TBL] [Abstract][Full Text] [Related]
30. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
[TBL] [Abstract][Full Text] [Related]
31. Efficiency of ranolazine in the patient with microvascular angina, atrial fibrillation and migraine.
Osovska NY; Kuzminova NV
Wiad Lek; 2016; 69(6):832-837. PubMed ID: 28214825
[TBL] [Abstract][Full Text] [Related]
32. Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
Fanaroff AC; James SK; Weisz G; Prather K; Anstrom KJ; Mark DB; Ben-Yehuda O; Alexander KP; Stone GW; Ohman EM
J Am Coll Cardiol; 2017 May; 69(18):2304-2313. PubMed ID: 28473136
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.
Bress AP; Dodson JA; King JB; Sauer BC; Reese T; Crook J; Radwanski P; Knippenberg K; Greene T; Nelson RE; Munger MA; Weintraub WS; LaFleur J
Am J Cardiol; 2018 Dec; 122(11):1809-1816. PubMed ID: 30292334
[TBL] [Abstract][Full Text] [Related]
34. Ranolazine: A Contemporary Review.
Rayner-Hartley E; Sedlak T
J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079
[No Abstract] [Full Text] [Related]
35. Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
Zweiker R; Aichinger J; Metzler B; Lang I; Wallner E; Delle-Karth G
Wien Klin Wochenschr; 2019 Apr; 131(7-8):165-173. PubMed ID: 30963332
[TBL] [Abstract][Full Text] [Related]
36. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
[TBL] [Abstract][Full Text] [Related]
37. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
[TBL] [Abstract][Full Text] [Related]
38. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
39. A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris.
Vellopoulou K; Kourlaba G; Maniadakis N; Vardas P
Int J Cardiol; 2016 May; 211():105-11. PubMed ID: 26994453
[TBL] [Abstract][Full Text] [Related]
40. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
